RxDoctor Payments Data

Richard May, DO

Family Medicine · Lookout Mountain, GANPI 1366862229

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 81 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$321
  • Takeda Pharmaceuticals U.S.A., Inc.$226
  • Novo Nordisk$174
  • Pfizer$132
  • AbbVie$97
  • Exact Sciences$82
  • plus $548 from 22 others

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,580 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$113,786
Medicare patients
319
Services billed
1,721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban103$114,373
OzempicSemaglutide54$66,475
JardianceEmpagliflozin51$50,114
FarxigaDapagliflozin Propanediol30$43,744
TrulicityDulaglutide27$30,975
XareltoRivaroxaban29$27,873
JanuviaSitagliptin Phosphate23$27,477
MounjaroTirzepatide24$24,032
Breo ElliptaFluticasone/Vilanterol49$22,146
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$12,403
Bydureon BciseExenatide Microspheres11$8,953
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$5,256
Celecoxib99$3,754
Novolog FlexpenInsulin Aspart12$3,449
Gabapentin220$3,417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$132$114,373103 claims
Novo NordiskOzempic$174$66,47554 claims
Lilly USA, LLCTrulicity, Mounjaro$40$55,00651 claims
AstraZenecaFarxiga$27$43,74430 claims
AbbVieSynthroid$97$3,40354 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Lookout Mountain

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →